MARC details
000 -LEADER |
fixed length control field |
02367cam a2200325 a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-GiCUC |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
201216s2020 ua d f m 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EG-GiCUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GiCUC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
Deposite |
097 ## - Thesis Degree |
Thesis Level |
Ph.D |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
Cai01.08.08.Ph.D.2020.Yo.N |
100 0# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Youssef Ahmed Youssef Elsherif |
245 10 - TITLE STATEMENT |
Title |
Nanoparticles as an oral drug delivery system for certain drug / |
Statement of responsibility, etc. |
Youssef Ahmed Youssef Elsherif ; Supervised Mohamed Aly Kassem , Magdy Ibrahim Mohamed , Fathy Ibrahim Abdallah |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
الجسيمات متناهية الصغر كنظام توصيل فموى لعقار معين |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cairo : |
Name of publisher, distributor, etc. |
Youssef Ahmed Youssef Elsherif , |
Date of publication, distribution, etc. |
2020 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
156 P. : |
Other physical details |
charts , facsimiles ; |
Dimensions |
25cm |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Oxybutynin chloride is the gold first line treatment of nocturnal enuresis, oxybutynin chloride acts as a competitive antagonist of acetylcholine at postganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle. Although oxybutynin chloride is active, the drug bioavailability is only 6%. If the bioavailability of oxybutynin chloride is increased, this may increase the advantage of this important drug.The work in this thesis is divided into three parts: Part I: Formulation and evaluation of oxybutynin chloride nanosponge. Chapter I: Formulation and evaluation of oxybutynin chloride nanosponge by solvent evaporation method. Chapter II: Formulation and evaluation of oxybutynin chloride nanosponge by emulsion solvent diffusion/salting out method. Part II: Formulation and evaluation of oxybutynin chloride nanosponge compressed tablets. Chapter I: Formulation and evaluation of oxybutynin chloride nanosponge compressed tablets. Chapter II: Stability study of oxybutynin chloride nanosponge compressed tablets. Part III: Bioequivalence of oxybutynin chloride compressed tablets |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Certain drug |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Nanoparticles |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Oral drug delivery system |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Fathy Ibrahim Abdallah , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Magdy Ibrahim Mohamed , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mohamed Aly Kassem , |
Relator term |
|
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Nazla |
Reviser |
Revisor |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Shimaa |
Reviser |
Cataloger |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |